CINGULATE INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.71 USD | +0.28% |
|
+0.32% | -90.72% |
| 05-21 | FDA Clears Cingulate to File for Marketing Approval of CTx-1301 in the Treatment of ADHD | CI |
| 05-08 | Cingulate Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
- Stock Market
- Equities
- CING Stock
- News Cingulate Inc.
- Transcripts
